List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

GliaPharm Company

GliaPharm is a Swiss-based biotechnology company that offers treatments for neurological and psychiatric disorders.

GliaPharm's innovative therapeutic approach is to target glial cells , the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Their vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.

GliaPharm is a Swiss biotechnology company active in the development of treatments for neurological and psychiatric diseases.

The innovative therapeutic approach of GliaPharm is to target glial cells , or 'support cells' of neurons, to support and improve brain metabolism under certain pathological conditions. Their vision is to become a leader in the development of glial cell targeting agents that act as neuroprotective agents and maintain cognitive functions.

Invests into

Investors

Connections

Headquarters: Geneva, Geneve, Switzerland, Europe
Founded Date: 2016-01-01
Industry: Drug Discovery & Development
Employee Number: 1-10
Super Industry: Biopharma & Life Science Tools
Phone Number: 41 22 545 11 15
Investors: Alzheimer's Drug Discovery Foundation, FONGIT Innovation Fund, Gliaven, MassChallenge
Ipo Status: private
City: Geneva
Region: Geneve
Country: Switzerland
Founders: Ambroise Magistretti, Charles Finsterwald, Sylvain Lengacher
Register and Claim Ownership